ArticleAnnals of translational medicine2023

Efficacy and safety of anlotinib plus camrelizumab in treating retroperitoneal soft tissue sarcomas: a single-center retrospective cohort study.

Jianhui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.